Ibogaine is a naturally occurring alkaloid extracted from the root bark of Tabernanthe iboga, a plant native to Central Africa. Traditionally used in …
Ibogaine is a naturally occurring alkaloid extracted from the root bark of Tabernanthe iboga, a plant native to Central Africa. Traditionally used in …
Welcome to Reason Foundation’s newsletter on psychedelics policy. This edition covers:
The new legislative session has opened, with multiple states proposing bills to expand access to psilocybin and fund research. New Jersey will allocate $6 million to fund a pilot program for ...
A bill to conduct a clinical trial to study ibogaine, a psychedelic compound derived from the iboga plant of Central Africa as a potential …
This post is part of an ongoing series that summarizes state-based psychedelic reforms, intended for policy professionals.
House File 2085, sponsored by state Rep. John Wills (R- District 10), would establish a regulated system for psilocybin production and administration.
The bill creates a psilocybin production establishment licensing board within the Iowa Department of Health and Human Services, requires security systems at regulated sites, sets up registration ...
ALEC Veterans and Military Affairs Task Force Director Zachary Federico testified before the Maryland Senate Finance Committee on SB0527 in consideration of clinical trials on the use of ibogaine.
Read his testimony below:
Chairwoman Beidle, Vice Chairman Hayes, and Members of the Committee,
My name is Zach Federico, and I serve as the Director of the Veterans and Military Affairs Task Force at the American Legislative Exchange Council. Thank you for the opportunity to ...